Clinical Trials Directory

Trials / Completed

CompletedNCT02907242

Revealed Versus Concealed Cerebroplacental Ratio

Revealed Versus Concealed Criteria for Placental Insufficiency in Unselected Obstetric Population in Late Pregnancy: a Multicenter Randomized Controlled Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
11,582 (actual)
Sponsor
Hospital Clinic of Barcelona · Academic / Other
Sex
Female
Age
18 Years – 50 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to evaluate the role of an integrated strategy at selecting fetuses for delivery at term based on a combination of fetal biometry and cerebroplacental ratio (CPR) to reduce stillbirth rate and adverse perinatal outcome.

Detailed description

This is a multicenter, open-label randomized trial with groups in parallel. Singleton pregnancies are recruited after routine second trimester scan (19+0 to 22+6 weeks of gestation) and randomly allocated at that moment to revealed or concealed strategy. A routine scan will be booked at 36-37 weeks. For a reduction of the stillbirth rate of 3‰ (from 5‰ to 2‰), assuming a type I error of 5% and aiming for a power of 80% a total of 11,582 subjects (5791 per arm) were projected. The participating centers sum up 12,000 deliveries a year. It is not possible to blind participants, obstetricians, or outcome assessors to the study group. General hypothesis: A proportion of fetuses with "normal" growth as per current standards have placental insufficiency and restriction of their growth potential. These fetuses exhibit biophysical changes expressed by abnormal cerebroplacental ratio. A combination of this marker with fetal biometry for the detection of fetuses affected by fetal growth restriction could identify a group of babies on which labor induction once term is reached may prevent the occurrence of adverse outcomes. Specific hypothesis * The cerebroplacental ratio has predictive value in late pregnancy for placental insufficiency. * The cerebroplacental ratio could improve the effectiveness of late pregnancy screening for the prediction placental insufficiency-related complications.

Conditions

Interventions

TypeNameDescription
OTHERRevealmentCerebroplacental ratio revealment

Timeline

Start date
2016-05-04
Primary completion
2022-01-06
Completion
2022-01-06
First posted
2016-09-20
Last updated
2022-04-18

Locations

9 sites across 6 countries: Chile, Czechia, Israel, Mexico, Poland, Spain

Source: ClinicalTrials.gov record NCT02907242. Inclusion in this directory is not an endorsement.